RETURN TO PUBLICATIONS HOME PAGE

• Books and Book Chapters
• Review articles and editorials

• Original articles
• Guidelines and workshop reports
• Published abstracts

Daniels G. Blood group antibodies in haemolytic disease of the fetus and newborn. In: Hadley AG, Soothill P, eds. Alloimmune Disorders of Pregnancy. Anaemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge: Cambridge University Press, 2002:21-40.

Hadley AG, Soothill P, eds. Alloimmune Disorders of Pregnancy. Anaemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge: Cambridge University Press, 2002:21-40.

Kumpel B. Principles of antibody-mediated immune suppression and the prevention of maternal RhD alloimmunization. in: Alloimmune disorders of pregnancy. Eds: Andrew G Hadley, Peter Soothill. Cambridge University Press, 2002, pages 73-95.

Lucas G (2002) The immunological diagnosis of alloimmune neutropenia. In: Alloimmune disorders of pregnancy p235-252. Ed. A Hadley & P Soothill. (Cambridge University Press).

Daniels G  Human Blood Groups, 2nd edition. Oxford: Blackwell Science, 2002

Review Articles and Editorials

Anstee DJ - Progress towards a Blood Test for vCJD? Vox Sang 2002; 83,(suppl 1): 203-205

Daniels G, Crew V. The molecular basis of the Lutheran blood group antigens. Vox Sang 2002;83(suppl 1):189-192.

Daniels G, Poole J, de Silva M, Callaghan T, MacLennan S, Smith N. The clinical significance of blood group antibodies. Transfusion Med 2002, 12:287-295.

Kumpel BM. In vivo studies of monoclonal anti-D and the mechanism of immune suppression. Transfusion Clinique et Biologique 2002; 9: 9-14

Kumpel BM. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis). Immunology Letters 2002: 82: 67-73

Original Articles

Anstee DJ  Progress towards a blood test for vCJD?  Vox Sanguinis 2002: 83, 203-205 Suppl. 1 

Bhattacharya S, Makar Y, Laycock RA, Gooch A, Poole J, Hadley A. Outcome of consecutive pregnancies in a patient with Bombay (Oh) phenotype. Transf Med 2002;12: 379-382

Beckmann R, Toye AM, Smythe JS, Anstee DJ, Tanner MJA - An N-terminal GFP tag does not alter the functional expression to the plasma membrane of red cell and kidney anion exchanger (AE1) in mammalian cells. Mol Memb Biol, 2002, 19, 187-200

Blair A, Baker CL, Pamphilon DH, Judson PA. Ex vivo expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies. British Journal of Haematology 116, 912-919 (2002)

Green C, Coghlan G, Bizot M, Kasulke D, Bombail-Girard M, Wallace M, Lomas-Francis C, Daniels G. JAHK: a low frequency antigen associated with the rG complex of the Rh blood group system. Transfus Med 2002: 12: 55-61

Hellberg A, Poole J, Olsson ML. Molecular basis of globoside-deficient Pk blood group phenotype. J. Biol. Chem. 2002; 277:29455-29459.

Irshaid NM, Eicher NI, Hustinx H, Poole J, Olsson ML. Novel allelles at the JK blood group locus explain the absence of the erythrocyte urea transporter in European families. Br. J. Haematol. 2002; 116:445-453.

Knowles SM, Milkins CE, Chapman JF, Scott ML The United Kingdom National External Quality Assessment Scheme (Blood Transfusion Laboratory Practice): trends in proficiency and practice between 1985 and 2000. Transfus. Med. 2002; 12:11-23.

Kumpel BM. Monoclonal anti-D development programme. Transplant Immunology. 2002;10:199-204.

Matthes T, Tullen E, Poole J, Banks J, Nagy M, Stelling MJ, Boehlen F, Michel M, Beris P, Hustinx H, Crew V, Danials G. Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC. Transfusion 2002; 42:1448-1457

Poole J. The Screening, Identification and Use of Rare Blood. Vox Sang;83 (suppl 1) 99-100 (Proceedings paper ISBT 2002)

Rider J & Newton A. Electrochemiluminescent detection of bacteria in blood components. Transfus Med. 2002 Apr;12(2):115-23.

Ronghe M.D., Foot A.B.M., Cornish J.M., Steward C.G., Carrington D., Goulden N., Marks D.I., Oakhill A, Pamphilon D.H. The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation. British Journal of Haematology 2002; 118; 1124-1127

Roudier N, Ripoche P, Gane P, Le Pennec PY, Daniels G, Cartron JP, Bailly P. AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. J Biol Chem 2002;277:45854-45859.

Sohan K., Billington M., Pamphilon D., Goulden N., Kyle P. Normal growth and development following in utero diagnosis and treatment of homozygous a -thalassemia. British Journal of Obstetrics and Gynaecology 2002; 109; 1308-1310

Vinall LE, King M, Novelli M, Green CA, Daniels G, Hilkens J, Sarner M, Swallow DM. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 2002;123:41-49.

Yahalom V, Ellis MH, Poole J, Rahimi-Levene N, Shinar E, DaCosta Y, Manny N, Levene C. The rare Lu:-6 phenotype in Israel and the clinical significance of anti-Lu6. Transfusion 2002; 42:247-250.

Guidelines and Workshop Reports

Daniels G. Section 4: antibodies to other blood group antigens. Co-ordinator's Report. Tranfus. Clin. Biol. 2002: 9, 75-80

Flegel WA, Čurin-Šerbec V, Delamaire M, Donvito B, Ikeda H, Jorgensen J, Kumpel B, Le Pennec P-Y, PísačKa M, Tani Y, Uchikawa M, Wendel S, Wagner FF. Section 1B: Rh flow cytometry Coordinator’s report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfus Clin Biol 2002;9:33-42.

Kumpel BM, Beliard R, Brossard Y, Edelman L, de Haas M, Jackson DJ, Kooyman P, Ligthart PC, Monchatre E, Overbeeke MAM, Puillandre P, de Romeuf C, Wilkes AM. Section 1C. Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies tested in biological assays by five laboratories: coordinator's report. Transfusion Clinique et Biologique 2002; 9: 45-53

Lucas G, Rogers S, de Haas M, Porcelijn L, Bux J Report on the fourth international granulocyte immunology workshop ; progress toward quality assessment. Transfusion 2002; 42: 462-468.

Scott ML Section 1A: Rh Serology Co-ordinator’s report. Transfusion Clinique et Biologique 2002; 9: 23-29

Published Abstracts

Asher O, Bennett M, Blumenthal R, Yosephi L, Agupov M, Poole J, Shinar E, Levene C, Yahalom V. Anti-Lan in pregnancy: first cases in Israel. Abstracts of the 27^th Congress of the ISBT: P-067

Belfield H, Green CA, James J, Forbes B, Massey E, Hows J, Tanner MJA, Anstee DJ. Elevated expression of Lutheran and LW glycoproteins on red cells and erythroid precursors in haemoglobin SC disease. Transfusion Medicine 2002; 12: Suppl 1, abstract YS3

Blair A., Cox C.V., Goulden N.J., Evely R.S., Pamphilon D.H. Phenotypic characterisation of ALL progenitor cells in vitro and in vivo. 31^st Annual Scientific meeting of the International Society for Experimental Hematology. Montreal, July 2002 (Experimental Hematology 2002; 30, p91)

Blair A., Cox C., Evely R., Pamphilon D. Characterisation of ALL stem cells. BBTS XX Annual Scientific Meeting. Edinburgh, September 2002 (Transfusion Medicine 2002; 12 (Suppl 1), p55)

Broadberry RE, Farren TW, Kohler JA, Bevin SV, Yates S, Skidmore I, Poole J, Garratty G. Haemolytic anaemia associated with Tazobactam. Abstracts of the 27^th Congress of the ISBT: 675

Brown J., Totham A., Oakhill A., Marks D., Pamphilon D. Prophylactic granulocytes for high risk stem cell transplant (SCT) patients. BBTS XX Annual Scientific Meeting. Edinburgh, September 2002 (Transfusion Medicine 2002; 12 (Suppl 1), p6)

Browne S., Pamphilon D., Blair A. Optimising retroviral mediated transfer of CD80 and CD86 into ALL cells. BBTS XX Annual Scientific Meeting. Edinburgh, September 2002 (Transfusion Medicine 2002; 12 (Suppl 1), p55)

Bruce DG, Babb R, Poole J, Mounter P, Fitzgerald J. Group Oh with anti-H in pregnancy. Transf Med 2002; 12: Suppl 1 P18.

Crew VK, Green CA, Daniels GL. The molecular basis of LU5, LU6/LU9, LU8/LU14, LU13 and LU20 Lutheran blood group antigens. Transfusion Med 2002;12(suppl 1):20.

Cox C, Goulden N., Pamphilon D., Blair A. Optimising culture conditions for the growth of clonogenic acute lymphoblastic leukaemia cells. BBTS XX Annual Scientific Meeting. Edinburgh, September 2002 (Transfusion Medicine 2002; 12 (Suppl 1), p55)

Cox C., Goulden N., Pamphilon D., Blair A. Optimising culture conditions for the growth of clonogenic acute lymphoblastic leukaemia cells. 31^st Annual Scientific meeting of the International Society for Experimental Hematology. Montreal, July 2002 (Experimental Hematology 2002; 30, p92)

Daniels G. Blood grouping by molecular genetics – red cells. Transfusion Med 2002;12(suppl 1):11.

Daniels G, Crew V, Poole J, Reed M, Beatty C. A new high incidence antigen in the Lutheran Blood Group System. Abstracts of the 27^th Congress of the ISBT: P-441

Green CA, Daniels GL, Jung HH. Variable X-chromosome inactivation in five McLeod syndrome carriers from the same family. Transfusion Med 2002;12(suppl 1):4-5.

Hancock., J.P., Goulden N.J., Oakhill A., Knechtli C.J.C., Niooett J.P., Burke A.G., Garland R.J., Groves S., Cornish J., Pamphilon D., Steward C.G. The impact of minimal residual disease prior to conditioning and chimerism after BMT in childhood acute lymphoblastic leukaemia. VII Congress of the European Hematology Association. Florence, June 2002 (The Hematology Journal 2002; 3 (Suppl 1); 0007, p14)

Hellberg A, Thuresson B, Heier HE, Poole J, Olsson ML. Additional molecular bases of the clinically important p phenotype. Abstracts of the 27^th Congress of the ISBT: 368

Kijkornpan S, Tardtong P, Poole J, Suksomboonvong P, Khunmars R, Silthara T, Chuansumrit A, Roungsipragarn R. A successful treatment of Rh hemolytic cisease of the newborn from an Rhnull mother with anti-Rh29. Abstracts of the 27^th Congress of the ISBT: P-447.

Moppett J., Goulden N.J., Darbyshire P., Steward C.G., Hancock J., Garland R., Burke A.G., Groves S., Pamphilon D., Cornish J., Oakhill A. Further cytoreductive therapy prior to bone marrow transplant for MRD positive children with ALL. VII Congress of the European Hematology Association. Florence, June 2002 (The Hematology Journal 2002; 3 (Suppl 1); 0030, p21)

Pisacka M, Bolkova H&M, Jarolim P, Elsnerova M, Kooistka M, Beislova H, Pietrzykova M, Poole J, Wilkes A. Management of three pregnancies with fetomaternal incompatibility due to RBC high frequency antigens. Abstracts of the 27^th Congress of the ISBT: P-075

Poole J. Transfusing the Difficult Patient. Abstract of invited lecture. Transf Med 2002; 12: Suppl 1 S6

Poole J, Hustinx H, Warke N, Crew V, Martin P, Daniels G. A new allele of the KEL gene. Transf Med 2002; 12: Suppl 1 O1

Poole J, Banks J, Spring FA, Overbeeke MAM. A novel high incidence antigen on CD44 glycoprotein. Transf Med 2002; 12: Suppl 1 P25

Rodrigues MJ, Carrasco MH, Warke N, Poole J, Sancho MC, Chabert T, Sousa G. Identification of partial D antigen DBT, with allo anti-D in the serum. Transf Med 2002; 12: Suppl 1 P17.

Roudier N, Ripoche P, Gane P, Le Pennec PY, Daniels G, Cartron JP, Bailly P. Genetic basis of a human AQP3-null phenotype and identification of a novel blood group system, GIL. Vox Sang 2002;83(suppl 2):10.

Skidmore I, Lee E, Poole J. First example of anti-Ok^a in a non-Japanese individual and evidence for heterogeneity of Ok^a antigen. Transf Med 2002; 12: Suppl 1 P10.

Stamps R, Loades T, Beale J, Webster R, Warke N, Poole J. IgA class AIH with suppressed Kell antigens and antibody to a high incidence Kell antigen. Transf Med 2002; 12: Suppl 1 P33

Totham A., James J., Healy P., Heard P., Dunn P., Navarrete C., Pamphilon D. Use of G-CSF in British Bone Marrow Registry (BBMR) donors. BBTS XX Annual Scientific Meeting. Edinburgh, September 2002 (Transfusion Medicine 2002; 12 (Suppl 1), p8)

Totham A., Brown J., Williams K., Healy P., Potok D., Makrs D., Pamphilon D., Evely R., Pocock M., Steward D., Goulden N., Oakhill A., Cornish J., Jackson J., Massey E. GCSF stimulated related granulocyte donation: a problem shared. BBTS XX Annual Scientific Meeting. Edinburgh, September 2002 (Transfusion Medicine 2002; 12 (Suppl 1), p45)

Turton J.R., Heard P.T., Dunn P.P.J., Contreras M.C., Pamphilon D.H., Navarrete C.N. Analysis of the composition and operations of the British Bone Marrow Registry. BBTS XX Annual Scientific Meeting. Edinburgh, September 2002 (Transfusion Medicine 2002; 12 (Suppl 1), p56)

Yahalom V, Shinar E, Poole J, Asher O, Mendelson L, Levene C. The rare donor registry in Israel. Abstracts of the 27^th Congress of the ISBT: P-086

Warke N, Skidmore I, Poole J. Use of the MAIEA assay in the red cell reference laboratory. Transf Med 2002; 12: Suppl 1 P24